Surgical management of the axilla: do intramammary nodes matter?

American Journal of Surgery

Volumn 198, Issue 4, 2009, Pages 532-537

  Pugliese, Matthew S ^a   Stempel, Michelle M ^a   Cody III, Hiram S ^a   Morrow, Monica ^a   Gemignani, Mary L ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

ALND; Axillary lymph node dissection; CALND; Completion axillary lymph node dissection; Intramammary lymph nodes; Sentinel lymph node; Sentinel lymph node biopsy; SLN

Indexed keywords

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER INVASION; CANCER STAGING; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRAMAMMARY LYMPH NODE; LYMPH NODE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE BIOPSY; SURGICAL TECHNIQUE;

AXILLA; BREAST; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY;

EID: 70349471101     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2009.06.007     Document Type: Article

References (24)

1. Adair F., Berg J., Joubert L., et al. Long-term followup of breast cancer patients: the 30-year report. Cancer 33 (1974) 1145-1150
2. NIH consensus conference. Treatment of early-stage breast cancer. JAMA 265 (1991) 391-395
3. Moffat Jr. F.L. Lymph node staging surgery and breast cancer: potholes in the fast lane from more to less. J Surg Oncol 89 (2005) 53-60
4. Giuliano A.E., Kirgan D.M., Guenther J.M., et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220 (1994) 391-401
5. Krag D.N., Weaver D.L., Alex J.C., et al. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 2 (1993) 335-340
6. Kim T., Giuliano A.E., and Lyman G.H. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer 106 (2006) 4-16
7. Olson Jr. J.A., McCall L.M., Beitsch P., et al. Impact of immediate versus delayed axillary node dissection on surgical outcomes in breast cancer patients with positive sentinel nodes: results from American College of Surgeons Oncology Group Trials Z0010 and Z0011. J Clin Oncol 26 (2008) 3530-3535
8. Krag D.N., Anderson S.J., Julian T.B., et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 8 (2007) 881-888
9. Mansel R.E., Fallowfield L., Kissin M., et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial. J Natl Cancer Inst 98 (2006) 599-609
10. Purushotham A.D., Upponi S., Klevesath M.B., et al. Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. J Clin Oncol 23 (2005) 4312-4321
11. Veronesi U., Paganelli G., Viale G., et al. Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol 7 (2006) 983-990
12. Gill G. Sentinel-lymph-node-based management or routine axillary clearance?. One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): a randomized controlled surgical trial. Ann Surg Oncol 16 (2009) 266-275
13. McLaughlin S.A., Wright M.J., Morris K.T., et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol 26 (2008) 5220-5226
14. Cody III H.S. Sentinel lymph node biopsy for breast cancer: indications, contraindications, and new directions. J Surg Oncol 95 (2007) 440-442
15. Egan R.L., and McSweeney M.B. Intramammary lymph nodes. Cancer 51 (1983) 1838-1842
16. Cox C.E., Cox J.M., Ramos D., et al. Intramammary sentinel lymph nodes: what is the clinical significance?. Ann Surg Oncol 15 (2008) 1273-1274
17. Guth A.A., Mercado C., Roses D.F., et al. Intramammary lymph nodes and breast cancer: a marker for disease severity, or just another lymph node?. Am J Surg 192 (2006) 502-505
18. Hogan B.V., Peter M.B., Shenoy H., et al. Intramammary lymph node metastasis predicts poorer survival in breast cancer patients. Surg Oncol (2009 Jan 24) [Epub ahead of print]
19. Nassar A., Cohen C., Cotsonis G., et al. Significance of intramammary lymph nodes in the staging of breast cancer: correlation with tumor characteristics and outcome. Breast J 14 (2008) 147-152
20. Shen J., Hunt K.K., Mirza N.Q., et al. Intramammary lymph node metastases are an independent predictor of poor outcome in patients with breast carcinoma. Cancer 101 (2004) 1330-1337
21. Cody III H.S., Fey J., Akhurst T., et al. Complementarity of blue dye and isotope in sentinel node localization for breast cancer: univariate and multivariate analysis of 966 procedures. Ann Surg Oncol 8 (2001) 13-19
22. Singletary S.E., and Connolly J.L. Breast cancer staging: working with the sixth edition of the AJCC Cancer Staging Manual. CA Cancer J Clin 56 (2006) 37-47
23. Intra M., Garcia-Etienne C.A., Renne G., et al. When sentinel lymph node is intramammary. Ann Surg Oncol 15 (2008) 1304-1308
24. Park J., Fey J.V., Naik A.M., et al. A declining rate of completion axillary dissection in sentinel lymph node-positive breast cancer patients is associated with the use of a multivariate nomogram. Ann Surg 245 (2007) 462-468